FDA vows to overhaul drug safety system (St. Louis Post-Dispatch)
WASHINGTON — The Food and Drug Administration pledged Tuesday to undertake a major overhaul of its drug safety system, just months after a blue-ribbon panel of medical and legal experts concluded that the agency’s priorities were skewed toward approving new medications without enough follow-up of risky side effects.